SCHEMBL46303

SCHEMBL46303

COc1ncc(C)cc1N1CCCC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.38
GAA P10253 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
PIP4K2A P48426 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LRRK2 Q5S007 2/20 0.37
NPC1 O15118 1/20 0.37
HTT P42858 1/20 0.37
LMNA P02545 2/20 0.37
FFAR1 O14842 2/20 0.36
FFAR4 Q5NUL3 2/20 0.36
CDK2 P24941 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
MAPT P10636 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29527139 0.84 HSD17B10 (0.41) HSD17B10L3MBTL1CYP11B1CYP11B2PIP4K2A
SCHEMBL29066214 0.84 HSD17B10 (0.41) HSD17B10L3MBTL1CYP11B1CYP11B2PIP4K2A
SCHEMBL29066236 0.84 HSD17B10 (0.44) HSD17B10L3MBTL1CYP11B1CYP11B2PIP4K2A
SCHEMBL29527271 0.84 HSD17B10 (0.44) HSD17B10L3MBTL1CYP11B1CYP11B2PIP4K2A
SCHEMBL24802440 0.77 CYP17A1 (0.37) CYP11B2
SCHEMBL46329 0.77 SMN1; SMN2 (0.40) HSD17B10L3MBTL1GAACYP11B1CYP11B2
SCHEMBL29066185 0.75 KDM4E (0.40) HSD17B10L3MBTL1PIP4K2ASMN1; SMN2NPC1
SCHEMBL29527699 0.75 FFAR1 (0.40) HSD17B10CYP11B1CYP11B2PIP4K2AFFAR1
SCHEMBL29066188 0.75 FFAR1 (0.40) HSD17B10CYP11B1CYP11B2PIP4K2AFFAR1
SCHEMBL29526566 0.75 HSD17B10 (0.34) HSD17B10CYP11B1CYP11B2PIP4K2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011151436-A2 NOVEL COMPOUNDS, METHOD FOR USE THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM EUROSCREEN S.A. (BE) 2011-12-08 WO disclosed